Yarrow Bioscience Inc
Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 11 Mar 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Valuation data incomplete
Some financial data for this company couldn't be reliably verified. This may affect its score.
More details →Yarrow Bioscience Inc — Overview & Financial Snapshot
Yarrow Bioscience Inc (NasdaqCM: YARW) is a Healthcare company, ranked #5,525 of 6,774 companies globally and #3,016 of 4,000 in United States on PositoAI, with a Positivity Score of 17,060. Its market capitalisation is ₹1,721.36 Cr ($182.37M) and P/B ratio is 8.27. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.
For financial statements, ratio trends and score history, Go Deep →